This live web event has ended. Thank you for attending.
The IASP 2022 World Congress on Pain took place from 19-23 September 2022, in Toronto, Canada. As a part of the World Congress Virtual Program, IASP will host eleven 90-minute Post-Congress webinars. These webinars will provide registrants with practical reviews of current research and therapies surrounding pain and will feature live Q&A sessions with international experts in pain management and pain research. The Virtual Program is available to all IASP 2022 World Congress on Pain registered attendees (i.e., both in-person and virtual registrants).
There are three pricing tiers for this Post-Congress webinar:
1) FREE to all IASP 2022 World Congress on Pain registered attendees (registrants must enter the promo code provided via email during checkout).
2) $5.00 USD for all IASP members that did not register to attend the IASP 2022 World Congress on Pain.
3) $25.00 USD for all IASP non-members.
The Psychedelic Renaissance: Pharmacology and History, Neuroscience and Clinical Efficacy
This first Post-Congress webinar introduces the audience to the current knowledge of this emerging field and its potential relevance to pain management.
The first presenter, Kirran Ahmad, MD, will introduce background information on classical psychedelics with their ethnopharmacology, recent history, legal aspects, and pharmacology.
The second presenter, Gabriella Gobbi, MD, PhD, will discuss psychedelic mechanisms of action as modulators of neurotransmitter systems, neuroplastic agents, immune modulation, anti-inflammatory effects, activity and connectivity of neural networks, and altered functional processing.
The third presenter, Emmanuelle Schindler, MD, PhD, will then review the investigational non-invasive measuring techniques and clinical efficacy of these agents in relation to headache disorders, other chronic pain conditions, suffering in terminal illness, depression, PTSD, and addiction.
There will be a live Q&A session following each presentation.
-- Kirran Ahmad, MD, Imperial College London, UK
Introduction to Psychedelics
-- Gabriella Gobbi, MD, PhD, McGill University, Montreal, Canada
The Neuroscience of Psychedelics
-- Emmanuelle Schindler MD, PhD, Yale School of Medicine; Veterans Affairs Connecticut Health System, USA
The Clinical Efficacy of Psychedelics
-- John Akers, MD, Royal Perth Hospital, Australia (moderator)